Back to Search
LUIS MARINI, DMD
DMD
Pediatric Dentistry
NPI: 1659562478Individual
Specialties, Licenses & Credentials
Pediatric DentistryPrimary
Dentist — Pediatric Dentistry
Code: 1223P0221X
802(PR)
Research & Publications (20)
Early colonization of stone by freshwater lichens of restored habitats: a case study in northern Italy.
PMID 19589560·Sci Total Environ·2009
8-other
Drug waste minimisation and cost-containment in Medical Oncology: two-year results of a feasibility study.
PMID 18380901·BMC Health Serv Res·2008
8-other
Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial.
PMID 17207911·Eur Urol·2007
3-trial
Synthesis and primary cytotoxicity evaluation of arylmethylenenaphthofuranones derivatives.
PMID 16918079·J Enzyme Inhib Med Chem·2006
4-observational
The community barometer: a breast health needs assessment tool for community-based organizations.
PMID 16861589·Health Educ Behav·2006
8-other
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy.
PMID 16630670·Lung Cancer·2006
3-trial
Pharmacokinetic study of intravesical gemcitabine in carcinoma in situ of the bladder refractory to bacillus Calmette-Guérin therapy.
PMID 16327296·Urol Int·2005
3-trial
Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.
PMID 16225511·BJU Int·2005
6-review
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study.
PMID 16052214·Br J Cancer·2005
3-trial
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer.
PMID 15956971·Br J Cancer·2005
3-trial
Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells.
PMID 15795320·Mol Pharmacol·2005
4-observational
Qualitative multiplex RT-PCR for simultaneous detection of hepatitis C virus and human immunodeficiency virus in plasma samples.
PMID 15606634·Clin Microbiol Infect·2004
4-observational
Rationale for the use of gemcitabine in breast cancer (Review).
PMID 14719116·Int J Oncol·2004
6-review
Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.
PMID 12923612·Naunyn Schmiedebergs Arch Pharmacol·2003
4-observational
h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT.
PMID 12684263·Br J Pharmacol·2003
7-preclinical
Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
PMID 12181435·Mol Pharmacol·2002
7-preclinical
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.
PMID 11753976·Cancer·2001
3-trial
[Thrombophilia and thromboembolic disease. A case report].
PMID 11733740·Minerva Cardioangiol·2001
5-case
Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis.
PMID 11343377·Am J Hematol·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 654 AVE MUNOZ RIVERA, SUITE 1111
SAN JUAN, PR 00918 - Phone
- (787) 553-9303
Quick Facts
- NPI
- 1659562478
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile